Methylene blue for distributive shock: a potential new use of an old antidote

J Med Toxicol. 2013 Sep;9(3):242-9. doi: 10.1007/s13181-013-0298-7.

Abstract

Methylene blue is used primarily in the treatment of patients with methemoglobinemia. Most recently, methylene blue has been used as a treatment for refractory distributive shock from a variety of causes such as sepsis and anaphylaxis. Many studies suggest that the nitric oxide-cyclic guanosine monophosphate (NO-cGMP) pathway plays a significant role in the pathophysiology of distributive shock. There are some experimental and clinical experiences with the use of methylene blue as a selective inhibitor of the NO-cGMP pathway. Methylene blue may play a role in the treatment of distributive shock when standard treatment fails.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Anaphylaxis / physiopathology
  • Animals
  • Antidotes / adverse effects
  • Antidotes / pharmacology
  • Antidotes / therapeutic use*
  • Cyclic GMP / antagonists & inhibitors
  • Cyclic GMP / metabolism
  • Drug Resistance
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / enzymology
  • Endothelium, Vascular / metabolism
  • Enzyme Inhibitors / adverse effects
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Isoenzymes / antagonists & inhibitors
  • Isoenzymes / chemistry
  • Isoenzymes / metabolism
  • Methylene Blue / adverse effects
  • Methylene Blue / pharmacology
  • Methylene Blue / therapeutic use*
  • Models, Biological*
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / enzymology
  • Muscle, Smooth, Vascular / metabolism
  • Nitric Oxide / antagonists & inhibitors
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / chemistry
  • Nitric Oxide Synthase / metabolism
  • Second Messenger Systems / drug effects*
  • Sepsis / physiopathology
  • Shock / drug therapy*
  • Shock / etiology
  • Shock / metabolism
  • Shock, Cardiogenic / drug therapy
  • Shock, Cardiogenic / etiology
  • Shock, Cardiogenic / metabolism
  • Vascular Resistance / drug effects

Substances

  • Antidotes
  • Enzyme Inhibitors
  • Isoenzymes
  • Nitric Oxide
  • Nitric Oxide Synthase
  • Cyclic GMP
  • Methylene Blue